Payden & Rygel’s HCA Healthcare HCA Stock Holding History

Payden & Rygel’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-40,500	Closed	-$15.5M	–	118
2025 Q2	$15.5M	Sell	40,500 -4,600	-10%	-$1.66M	1.28%	38
2025 Q1	$15.6M	Buy	+45,100	New	+$14.5M	1.34%	32

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Payden & Rygel's HCA Position: Q3 2025 in Review

Payden & Rygel sold out of HCA Healthcare (HCA) in Q3 2025, closing a stake of 40,500 shares — an estimated $15.5M sold.

Payden & Rygel first reported a position in HCA in Q1 2025 and held it in 2 quarters. The position peaked at $15.6M in Q1 2025. 1,286 funds tracked by Wall St. Rank hold HCA as of Q3 2025.

Payden & Rygel reported no remaining HCA Healthcare position as of Q3 2025 after selling out during the quarter.
Payden & Rygel sold 40,500 HCA Healthcare shares in Q3 2025, an estimated $15.5M.
Payden & Rygel first reported a position in HCA Healthcare in Q1 2025 and held it in 2 quarters.
Payden & Rygel's HCA Healthcare position peaked at $15.6M in Q1 2025.
1,286 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2025.

Based on Payden & Rygel's 13F filing for Q3 2025, filed 10 Nov 2025.